General Information of the Protein
Protein ID
PT03645
Protein Name
Nucleotide-binding oligomerization domain-containing protein 1
Secondarily
Protein Name
Caspase recruitment domain-containing protein 4
Gene Name
NOD1
Secondarily
Gene Name
CARD4
Sequence
MEEQGHSEMEIIPSESHPHIQLLKSNRELLVTHIRNTQCLVDNLLKNDYFSAEDAEIVCACPTQPDKVRKILDLVQSKGEEVSEFFLYLLQQLADAYVDLRPWLLEIGFSPSLLTQSKVVVNTDPVSRYTQQLRHHLGRDSKFVLCYAQKEELLLEEIYMDTIMELVGFSNESLGSLNSLACLLDHTTGILNEQGETIFILGDAGVGKSMLLQRLQSLWATGRLDAGVKFFFHFRCRMFSCFKESDRLCLQDLLFKHYCYPERDPEEVFAFLLRFPHVALFTFDGLDELHSDLDLSRVPDSSCPWEPAHPLVLLANLLSGKLLKGASKLLTARTGIEVPRQFLRKKVLLRGFSPSHLRAYARRMFPERALQDRLLSQLEANPNLCSLCSVPLFCWIIFRCFQHFRAAFEGSPQLPDCTMTLTDVFLLVTEVHLNRMQPSSLVQRNTRSPVETLHAGRDTLCSLGQVAHRGMEKSLFVFTQEEVQASGLQERDMQLGFLRALPELGPGGDQQSYEFFHLTLQAFFTAFFLVLDDRVGTQELLRFFQEWMPPAGAATTSCYPPFLPFQCLQGSGPAREDLFKNKDHFQFTNLFLCGLLSKAKQKLLRHLVPAAALRRKRKALWAHLFSSLRGYLKSLPRVQVESFNQVQAMPTFIWMLRCIYETQSQKVGQLAARGICANYLKLTYCNACSADCSALSFVLHHFPKRLALDLDNNNLNDYGVRELQPCFSRLTVLRLSVNQITDGGVKVLSEELTKYKIVTYLGLYNNQITDVGARYVTKILDECKGLTHLKLGKNKITSEGGKYLALAVKNSKSISEVGMWGNQVGDEGAKAFAEALRNHPSLTTLSLASNGISTEGGKSLARALQQNTSLEILWLTQNELNDEVAESLAEMLKVNQTLKHLWLIQNQITAKGTAQLADALQSNTGITEICLNGNLIKPEEAKVYEDEKRIICF
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Unclassified protein
Function
Pattern recognition receptor (PRR) that detects bacterial peptidoglycan fragments and other danger signals and thus participates in both innate and adaptive immune responses (PubMed:11058605, PubMed:12796777, PubMed:12791997, PubMed:15044951, PubMed:16172124, PubMed:19043560, PubMed:22672233, PubMed:27099311). Specifically recognizes and binds gamma-D-glutamyl-meso-diaminopimelic acid (iE-DAP), a dipeptide present in peptidoglycan of Gram-negative bacteria (PubMed:12871942, PubMed:12796777, PubMed:12791997, PubMed:16211083, PubMed:16172124). Preferentially binds iE-DAP in tripeptide-containing muropeptides (MurNAc-TriDAP or TriDAP) (PubMed:16211083). Ligand binding triggers oligomerization that facilitates the binding and subsequent activation of the proximal adapter receptor-interacting RIPK2 (PubMed:12796777, PubMed:12791997, PubMed:17054981). Following recruitment, RIPK2 undergoes 'Met-1'- (linear) and 'Lys-63'-linked polyubiquitination by E3 ubiquitin-protein ligases XIAP, BIRC2, BIRC3 and the LUBAC complex, becoming a scaffolding protein for downstream effectors, triggering activation of the NF-kappa-B and MAP kinases signaling (PubMed:10880512, PubMed:12791997, PubMed:19043560). This in turn leads to the transcriptional activation of hundreds of genes involved in immune response (PubMed:10880512, PubMed:19043560). Also acts as a regulator of antiviral response elicited by dsRNA and the expression of RLR pathway members by targeting IFIH1 and TRAF3 to modulate the formation of IFIH1-MAVS and TRAF3-MAVS complexes leading to increased transcription of type I IFNs (PubMed:32169843). Also acts as a regulator of autophagy via its interaction with ATG16L1, possibly by recruiting ATG16L1 at the site of bacterial entry (By similarity). Besides recognizing pathogens, also involved in the endoplasmic reticulum stress response: acts by sensing and binding to the cytosolic metabolite sphingosine-1-phosphate generated in response to endoplasmic reticulum stress, initiating an inflammation process that leads to activation of the NF-kappa-B and MAP kinases signaling (PubMed:27007849, PubMed:33942347). In addition, plays a role in insulin trafficking in beta cells in a cell-autonomous manner (By similarity). Mechanistically, upon recognizing cognate ligands, NOD1 and RIPK2 localize to insulin vesicles where they recruit RAB1A to direct insulin trafficking through the cytoplasm (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
Q9Y239

Secondarily ID:
B4DTU3
Q549U4
Q8IWF5
    Show/Hide
HGNC ID
HGNC:16390
Subcellular Location
Cell membrane
Apical cell membrane
Basolateral cell membrane
Cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0505722
2-Amino-6-((R)-4-carboxy-4-(dodecylamino)butanamido)heptanedioic Acid
   Show/Hide
C24H45N3O7
 1
1
EC50 = 0.023 nM
   TI
   LI
   LO
   TS
CP0505721
2-Amino-6-((R)-4-carboxy-4-dodecanamidobutanamido)heptanedioic Acid
   Show/Hide
C24H43N3O8
 1
1
EC50 = 0.027 nM
   TI
   LI
   LO
   TS
CP0474419
2-Amino-6-((R)-4-amino-5-oxo-5-(undecyloxy)pentanamido)heptanedioic Acid
   Show/Hide
C23H43N3O7
 1
1
EC50 = 0.066 nM
   TI
   LI
   LO
   TS
CP0437178
2-Amino-6-((R)-4-dodecanamido-5-ethoxy-5-oxopentanamido)heptanedioic Acid
   Show/Hide
C26H47N3O8
 1
1
EC50 = 0.069 nM
   TI
   LI
   LO
   TS
CP0490822
2-Amino-6-((R)-4-carboxy-4-(dihexadecylamino)butanamido)heptanedioic Acid
   Show/Hide
C44H85N3O7
 1
1
EC50 = 0.12 nM
   TI
   LI
   LO
   TS
CP0539461
2-Amino-6-((R)-4-dodecanamido-5-oxo-5-(undecyloxy)pentanamido)heptanedioic Acid
   Show/Hide
C35H65N3O8
 1
1
EC50 = 0.134 nM
   TI
   LI
   LO
   TS
CP0395975
(2R)-5-((6-Amino-1,7-diethoxy-1,7-dioxoheptan-2-yl)amino)-2-dodecanamido-5-oxopentanoicAcid
   Show/Hide
C28H51N3O8
 1
1
EC50 = 0.145 nM
   TI
   LI
   LO
   TS
CP0505724
diethyl 2-amino-6-[[(4R)-4-amino-5-oxo-5-undecylsulfanylpentanoyl]amino]heptanedioate
   Show/Hide
C27H51N3O6S
 1
1
EC50 = 0.181 nM
   TI
   LI
   LO
   TS
CP0501409
2-Amino-6-((R)-4-carboxy-4-(dioctylamino)butanamido)heptanedioic Acid
   Show/Hide
C28H53N3O7
 1
1
EC50 = 0.2 nM
   TI
   LI
   LO
   TS
CP0437177
(15R)-10,6-Dibenzyl 15-Ethyl-2,2-dimethyl-4,12,17-trioxo-3-oxa-5,11,16-triazaoctacosane-6,10,15-tricarboxylate
   Show/Hide
C24H45N5O7
 1
1
EC50 = 0.238 nM
   TI
   LI
   LO
   TS
CP0505726
(R)-2-Amino-6-((R)-4-carboxy-4-dodecanamidobutanamido)hexanoic Acid
   Show/Hide
C23H43N3O6
 1
1
EC50 = 0.37 nM
   TI
   LI
   LO
   TS
CP0490823
2-Amino-6-(5-oxo-5-(undecyloxy)pentanamido)heptanedioic Acid
   Show/Hide
C23H42N2O7
 1
1
EC50 = 0.39 nM
   TI
   LI
   LO
   TS
CP0395976
2-Amino-6-(4-dodecanamidobutanamido)heptanedioic Acid
   Show/Hide
C23H43N3O6
 1
1
EC50 = 0.504 nM
   TI
   LI
   LO
   TS
CP0501408
2-((R)-4-Amino-4-carboxybutanamido)-6-dodecanamidoheptanedioic Acid
   Show/Hide
C24H43N3O8
 1
1
EC50 = 0.55 nM
   TI
   LI
   LO
   TS
CP0501412
(S)-6-Amino-2-((R)-4-carboxy-4-dodecanamidobutanamido)hexanoic Acid
   Show/Hide
C23H43N3O6
 1
1
EC50 = 0.57 nM
   TI
   LI
   LO
   TS
CP0522931
2-((R)-4-Carboxy-4-dodecanamidobutanamido)-6-dodecanamidoheptanedioic Acid
   Show/Hide
C36H65N3O9
 1
1
EC50 = 0.58 nM
   TI
   LI
   LO
   TS
CP0505723
2-((R)-4-Carboxy-4-dodecanamidobutanamido)-6-guanidinoheptanedioic Acid
   Show/Hide
C25H45N5O8
 1
1
EC50 = 0.622 nM
   TI
   LI
   LO
   TS
CP0539460
2-Amino-6-((R)-4-amino-5-oxo-5-(undecylamino)pentanamido)heptanedioic Acid
   Show/Hide
C23H44N4O6
 1
1
EC50 = 0.826 nM
   TI
   LI
   LO
   TS
CP0474420
(S)-2-Amino-6-((R)-4-carboxy-4-dodecanamidobutanamido)hexanoic Acid
   Show/Hide
C23H43N3O6
 1
1
EC50 = 0.96 nM
   TI
   LI
   LO
   TS
CP0933358
(2R)-5-((4-(2-Amino-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-1-carboxybutyl)amino)-2-dodecanamido-5-oxopentanoic Acid
   Show/Hide
C25H43N5O7
 1
1
EC50 = 1.31 nM
   TI
   LI
   LO
   TS
CP0511809
(2R)-2-Dodecanamido-5-oxo-5-((2-oxoazepan-3-yl)amino)pentanoic Acid
   Show/Hide
C23H41N3O5
 1
1
EC50 = 1.73 nM
   TI
   LI
   LO
   TS
CP0404988
2-((R)-4-Carboxy-4-dodecanamidobutanamido)heptanedioic Acid
   Show/Hide
C24H42N2O8
 1
1
EC50 > 100 nM
   TI
   LI
   LO
   TS
CP0501410
(R)-5-((5-Aminopentyl)amino)-2-dodecanamido-5-oxopentanoic Acid
   Show/Hide
C22H43N3O4
 1
1
EC50 > 100 nM
   TI
   LI
   LO
   TS
CP0505725
(R)-6-Amino-2-((R)-4-carboxy-4-dodecanamidobutanamido)hexanoic Acid
   Show/Hide
C23H43N3O6
 1
1
EC50 > 100 nM
   TI
   LI
   LO
   TS
CP0142376
(1-tosylbenzimidazol-2-yl)amine
   Show/Hide
C14H13N3O2S
 1
1
IC50 = 771 nM
   TI
   LI
   LO
   TS
CP0552892
5-ethyl-N-[2-fluoro-5-(2-methyl-4-oxoquinazolin-3-yl)phenyl]thiophene-2-sulfonamide
   Show/Hide
C21H18FN3O3S2
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0537944
2-[2-[3-[benzenesulfonyl(methyl)amino]propyl]benzimidazol-1-yl]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
   Show/Hide
C28H30N4O3S
 1
1
IC50 = 1660 nM
   TI
   LI
   LO
   TS
CP0422149
2-[2-[2-[benzenesulfonyl(methyl)amino]ethyl]benzimidazol-1-yl]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
   Show/Hide
C27H28N4O3S
 1
1
IC50 = 2560 nM
   TI
   LI
   LO
   TS
CP0487640
N-(2,3-dihydro-1H-inden-5-yl)-2-[2-[2-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]ethyl]benzimidazol-1-yl]acetamide
   Show/Hide
C32H33N5O3S
 1
1
IC50 = 2680 nM
   TI
   LI
   LO
   TS
CP0422098
N-(2,3-dihydro-1H-inden-5-yl)-2-[2-[2-[[5-(dimethylamino)naphthalen-1-yl]sulfonyl-methylamino]ethyl]benzimidazol-1-yl]acetamide
   Show/Hide
C33H35N5O3S
 1
1
IC50 = 3080 nM
   TI
   LI
   LO
   TS
CP0534935
2-[2-[3-(benzenesulfonamido)propyl]benzimidazol-1-yl]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
   Show/Hide
C27H28N4O3S
 1
1
IC50 = 9250 nM
   TI
   LI
   LO
   TS
CP0375351
4-benzyl-1-pentylbenzimidazol-2-amine
   Show/Hide
C19H23N3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0375352
N-(1-pentylbenzimidazol-2-yl)acetamide
   Show/Hide
C14H19N3O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0375357
1-pentyl-4-phenylbenzimidazol-2-amine
   Show/Hide
C18H21N3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0375359
3-pentylbenzo[f]benzimidazol-2-amine
   Show/Hide
C16H19N3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0400246
1-pentylbenzo[e]benzimidazol-2-amine
   Show/Hide
C16H19N3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0410599
1-pentyl-4-phenylmethoxybenzimidazol-2-amine
   Show/Hide
C19H23N3O
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0552400
3-[1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]-N-phenylpropanamide
   Show/Hide
C27H26N4O2
 1
1
IC50 = 12400 nM
   TI
   LI
   LO
   TS
CP0422101
tert-butyl 4-[2-[1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethylcarbamoyl]piperidine-1-carboxylate
   Show/Hide
C31H39N5O4
 1
1
IC50 = 13300 nM
   TI
   LI
   LO
   TS
CP0422152
N-[3-[1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]propyl]benzamide
   Show/Hide
C28H28N4O2
 1
1
IC50 = 17700 nM
   TI
   LI
   LO
   TS
CP0444014
N-[2-[1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]benzamide
   Show/Hide
C27H26N4O2
 2
1
IC50 = 27600 nM
   TI
   LI
   LO
   TS
2
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0422148
N-(2,3-dihydro-1H-inden-5-yl)-2-[2-[2-(pyridin-4-ylmethylamino)ethyl]benzimidazol-1-yl]acetamide
   Show/Hide
C26H27N5O
 1
1
IC50 = 27800 nM
   TI
   LI
   LO
   TS
CP0471660
2-[2-[2-(benzenesulfonamido)ethyl]benzimidazol-1-yl]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
   Show/Hide
C26H26N4O3S
 1
1
IC50 = 28200 nM
   TI
   LI
   LO
   TS
CP0552399
2-[2-[2-(benzylamino)ethyl]benzimidazol-1-yl]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
   Show/Hide
C27H28N4O
 1
1
IC50 = 30700 nM
   TI
   LI
   LO
   TS
CP0422102
N-(2,3-dihydro-1H-inden-5-yl)-2-[2-[2-(pyridin-3-ylsulfonylamino)ethyl]benzimidazol-1-yl]acetamide
   Show/Hide
C25H25N5O3S
 1
1
IC50 = 32000 nM
   TI
   LI
   LO
   TS
CP0565922
N-[2-[1-[2-(2,3-dihydro-1H-inden-5-ylamino)-2-oxoethyl]benzimidazol-2-yl]ethyl]-2-pyridin-4-ylacetamide
   Show/Hide
C27H27N5O2
 1
1
IC50 = 42300 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Pattern recognition receptor NOD1 (NOD1) )
Target Type Literature-reported Target